BLADEX, INC. — FY2013 Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2013; annual report filed April 25, 2014. Although the request refers to 2013 Q4, this filing reports full-year results, not standalone quarterly results. Financial statements are audited under U.S. GAAP.
Business context
Bladex is a Panama-based specialized bank focused on trade finance and financial intermediation in Latin America and the Caribbean. Its main operating segments are Commercial and Treasury. It does not provide retail banking. In 2013, the Bank sold its Asset Management Unit, while retaining a majority investment in the Alpha4X Feeder Fund.
Key financial metrics
| Metric | FY2013 / year-end | FY2012 / year-end |
|---|---|---|
| Interest income | $205.3 million | $192.4 million |
| Net interest income | $123.1 million | $105.0 million |
| Net interest margin / spread | 1.75% / 1.55% | 1.70% / 1.44% |
| Net fees and commissions | $13.7 million | $10.0 million |
| Consolidated net income | $80.6 million | $93.3 million |
| Net income attributable to Bladex stockholders | $84.8 million; diluted EPS $2.20 | $93.0 million; diluted EPS $2.45 |
| Operating expenses | $54.3 million | $55.8 million |
| Operating cash flow | $54.6 million | $97.1 million |
| Total assets | $7.47 billion | $6.76 billion |
| Loans | $6.15 billion | $5.72 billion |
| Deposits | $2.36 billion | $2.32 billion |
| Stockholders’ equity | $858.0 million | $826.5 million |
| Liquidity | $831 million; 11.1% of assets and 35.2% of deposits | $690 million; 10.2% of assets and 29.8% of deposits |
| Capital | Tier 1 ratio 15.9%; total capital ratio 17.1%; leverage 8.7x | Tier 1 ratio 17.9%; total capital ratio 19.2%; leverage 8.2x |
Cash flows were $54.6 million from operating activities, $(601.6) million from investing activities and $685.2 million from financing activities; cash and cash equivalents increased $138.2 million to $830.7 million. Total liabilities were $6.56 billion. Year-end funding included $2.71 billion of short-term borrowings and debt, $286 million of repurchase agreements, and $1.15 billion of long-term borrowings and debt.
Material changes versus FY2012
- Stockholder-attributable net income declined 9% to $84.8 million, despite 17% growth in net interest income. Management attributed the decline mainly to investment-fund losses, smaller credit-provision reversals, and the absence of FY2012’s $5.6 million gain on sale of premises and equipment.
- Net investment-fund trading moved to a $6.7 million loss from a $7.0 million gain. Fees and commissions rose 36%, mainly from letters of credit and loan intermediation; expenses fell 3%.
- The commercial portfolio grew 11% to $6.63 billion and total loans grew 8%. Credit disbursements reached a reported record $14.28 billion. About 73% of loans mature within one year.
- Credit quality remained strong by reported measures: non-accrual loans were $3.1 million (0.05% of loans), versus none in 2012. The loan-loss allowance was $72.8 million, and allowance coverage fell to 1.18% from 1.31%; the Bank recorded a $1.6 million loan-provision reversal, compared with an $8.3 million reversal in 2012.
- Liquidity increased, while funding shifted toward shorter maturities: short-term borrowings and debt plus repos rose to $2.99 billion, and long-term borrowings and debt fell 39% to $1.15 billion. Average funding cost declined to 1.33% from 1.63%.
- Tier 1 capital declined to 15.9% from 17.9%, while leverage rose to 8.7x from 8.2x, as the Bank deployed capital toward growth. Stockholders’ equity increased to $858 million.
Outlook, risks and unusual items
- Outlook: No numerical earnings or portfolio guidance is provided. Management’s stated strategy is to grow in stable, high-growth regional markets, broaden its client base, develop sector-specific offerings, and expand products such as factoring, vendor finance, syndications and structured trade finance.
- Regional and credit concentration: Approximately 63% of the credit portfolio was concentrated in Brazil, Colombia, Peru, Mexico and Chile. Oil and gas represented 29% of loans to private corporations, state-owned organizations and middle-market companies. A regional downturn, borrower stress, currency controls or devaluation could impair repayment and asset quality.
- Funding and liquidity: About 38% of funding was reported as short-term borrowings and debt from international private banks. Five depositors represented 57% of deposits; central and state-owned banks accounted for about 78%. Panama has no traditional central bank lender of last resort. Ratings downgrades or market disruption could raise funding costs or restrict access.
- Market and operating risks: Interest-rate mismatches may reduce net interest income; market volatility can affect investment and derivative values. The filing also identifies competition, information-system failures, operational errors, and regulatory/compliance risks, including Dodd-Frank/Volcker Rule and FATCA requirements.
- Asset-management transaction: The sale closed in the second quarter of 2013 and generated a $455,000 gain, while the unit’s operations were presented as discontinued. Bladex retained a 55.87% interest in Alpha4X Feeder Fund and committed to remain an investor, net of contractual redemptions, through March 31, 2016.
- Dividends: The Board raised the quarterly dividend from $0.30 to $0.35 per share for Q4 2013, a 17% increase. FY2013 dividends declared totaled $48.1 million; the filing reports no special dividend.
- Controls and contingencies: Deloitte issued unqualified opinions on the financial statements and internal control over financial reporting; management also concluded disclosure controls were effective. Off-balance-sheet credit arrangements totaled $480.4 million, with a $5.2 million related reserve. The Bank reported no material litigation and compliance with its financial covenants and Panamanian lending limits.
Important facts for investors to verify
- Reconcile the distinction between consolidated net income of $80.6 million and $84.8 million attributable to Bladex stockholders, including the effect of redeemable noncontrolling interests.
- Review the investment-fund valuation, remaining Alpha4X exposure, redemption terms and the investment commitment through March 2016.
- Assess the implications of shorter-term wholesale funding growth, large-depositor concentration, pledged securities and the maturity profile of borrowings.
- Evaluate whether the lower allowance coverage and the $3.1 million impaired/non-accrual loan remain appropriate as the loan book expands, particularly in concentrated countries and sectors.
- Confirm capital and leverage trends, dividend sustainability, and any subsequent developments affecting ratings, regional exposures, regulation or funding access.